DSS30 is a P25/CDK5 inhibitor that reduces beta-amyloid (Abeta) secretion by inhibiting amyloid precursor protein lyase 1 (BACEl) phosphorylation. DSS30 can be used in the study of neurodegenerative diseases such as Alzheimers disease[1].
Molecular Weight:
367.87
CAS Number:
[883027-32-5]
Formula:
C16H14ClNO3S2
Target:
Amyloid-beta,CDK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
